Posted By
News On December 15, 2008 - 5:30am
Washington, D.C. – Researchers at Georgetown University Medical Center have found a gene they say is inactivated in two aggressive cancers – malignant melanoma, a form of skin cancer, and glioblastoma multiforme, a lethal brain tumor. They add that because this gene, known as PTPRD, has recently been found to be inactivated in several other cancers as well, their discovery suggests that PTPRD may play a tumor suppressor role in a wide variety of different cancers.
The findings are published in the December 15 issue of Cancer Research.
Posted By
News On December 15, 2008 - 5:30am
Westchester, Ill. –A study in the Dec. 15 issue of the Journal of Clinical Sleep Medicine shows that after a one-hour delay of school start times, teens increased their average nightly hours of sleep and decreased their "catch-up sleep" on the weekends, and they were involved in fewer auto accidents.
Posted By
News On December 15, 2008 - 5:30am
Westchester, Ill. –A study in the Dec. 15 issue of the Journal of Clinical Sleep Medicine is the first to show the full clinical picture of comorbid conditions associated with obstructive sleep apnea (OSA), quantify their frequency of occurrence and reveal their possible interrelationships.
Posted By
News On December 15, 2008 - 5:30am
ATLANTA –Dec. 15, 2008 – A new report from the American Cancer Society says despite unprecedented progress in reducing incidence and death rates from colorectal cancer, the gap between blacks and whites continues to grow. The latest data show death rates are about 45 percent higher in African American men and women than in whites. The data come from Colorectal Cancer Facts & Figures 2008-2010, the second edition of a report first issued in 2005.
Posted By
News On December 15, 2008 - 5:30am
Westchester, Ill. –A study in the Dec. 15 issue of the Journal of Clinical Sleep Medicine suggests that screening type 2 diabetes patients for obstructive sleep apnea (OSA) and treating those who have OSA with continuous positive airway pressure (CPAP) therapy could improve the management of their hyperglycemia and might favorably influence their long-term prognosis.
Posted By
News On December 15, 2008 - 5:10am
Wellcome Trust researchers have developed a new form of psychotherapy that has been shown to have the potential to treat more than eight out of ten cases of eating disorders in adults, a study out today reports.
This new "enhanced" form of cognitive behavioural therapy (CBT-E) builds on and improves the current leading treatment for bulimia nervosa as recommended by the National Institute of Health and Clinical Excellence (NICE). CBT-E is the first treatment to be shown to be suitable for the majority of cases of eating disorders.
Posted By
News On December 15, 2008 - 12:40am
You probably know that poor diet and lack of exercise can lead to dangerous deposits of fatty plaques in arteries. But it is not just the heart that is affected – blood flow can be blocked to the legs too, leading to pain when walking, immobility and even in extreme cases, amputation.
Approximately 20% of us will suffer from this peripheral artery disease (PAD) once we are 65 or over, and with risk factors including smoking, diabetes, obesity and high blood pressure it is on the rise. Surgical intervention can sometimes help, but the prognosis is not good.
Posted By
News On December 15, 2008 - 12:40am
Posted By
News On December 14, 2008 - 8:40pm
One of the fastest translations of a basic research discovery into a promising clinical trial for an "untreatable" and fatal disorder will be discussed publicly for the first time by the key players in this remarkable research story, on Sunday, Dec. 14, at the American Society for Cell Biology (ASCB)'s annual meeting in San Francisco.
The disease is Progeria, or Hutchinson-Gilford Progeria Syndrome (HGPS), a rare, accelerated aging disease that afflicts children.
Posted By
News On December 14, 2008 - 6:40pm
The immune system's battle against invading bacteria reaches its peak activity at night and is lowest during the day.
Experiments with the laboratory model organism, Drosophila melanogaster, reveal that the specific immune response known as phagocytosis oscillates with the body's circadian rhythm, according to Stanford researchers who presented their findings at the American Society for Cell Biology (ASCB) 48th Annual Meeting, Dec. 13-17, 2008 in San Francisco.